Ghrelin as a potential molecular marker of adrenal carcinogenesis: In vivo and in vitro evidence

被引：8

作者：

Komarowska, Hanna ^{[1
]}

Rucinski, Marcin ^{[2
]}

Tyczewska, Marianna ^{[2
]}

Sawicka-Gutaj, Nadia ^{[1
]}

Szyszka, Marta ^{[2
]}

Hernik, Aleksandra ^{[1
]}

Klimont, Anna ^{[1
]}

Milecka, Paulina ^{[2
]}

Migasiuk, Laura ^{[1
]}

Biczysko, Mateusz ^{[3
]}

Idasiak-Piechocka, Ilona ^{[4
]}

Karczewski, Marek ^{[5
]}

Ruchala, Marek ^{[1
]}

机构：

[1] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland

[2] Poznan Univ Med Sci, Dept Histol & Embryol, Poznan, Poland

[3] Poznan Univ Med Sci, Dept Gen Endocrinol & Gastroenterol Surg, Poznan, Poland

[4] Poznan Univ Med Sci, Dept Nephrol Transplantol & Internal Med, Poznan, Poland

[5] Poznan Univ Med Sci, Dept Gen & Transplantat Surg, Poznan, Poland

来源：

CLINICAL ENDOCRINOLOGY | 2018年 / 89卷 / 01期

关键词：

adrenal; adrenocortical carcinoma; ghrelin; IGF2; proliferative factor; ADRENOCORTICAL CARCINOMA; GENE-EXPRESSION; CELL-LINES; ACYLATED PEPTIDE; RNA DEGRADATION; BREAST-CANCER; GROWTH; TUMORS; RECEPTOR; TISSUES;

D O I：

10.1111/cen.13725

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ContextAdrenal tumours belong to one of the most prevalent neoplasms. It is a heterogeneous group with different aetiology, clinical manifestation and prognosis. Its histopathologic diagnosis is difficult and identification of differentiation markers for tumorigenesis is extremely valuable for diagnosis. DesignTo assess ghrelin expression and the relationship among ghrelin, IGF2 and the clinicopathological characteristics of adrenal tumours. To investigate the influence of ghrelin on ACC cell line proliferation. Materials and methodsExpression of ghrelin and IGF2 in a total of 84 adrenal tissue samples (30 adenoma, 12 hyperplasia, 8 myelolipoma, 20 pheochromocytoma, 7 carcinoma and 7 unchanged adrenal glands) were estimated. Every operated patient from whom samples were obtained underwent clinicopathological analysis. All the parameters were compared among the groups examined and correlations between these were estimated. H295R cell line was incubated with ghrelin to assess its effect on proliferation and migration rate. ResultsThe highest ghrelin expression was observed in carcinoma samples and the lowest in the control group. Ghrelin expression was 21 times higher in carcinoma (P=.017) and 2.4 times higher in adenoma (P=.029) compared with controls. There were no statistically significant differences between myelolipoma (P=.093) and pheochromocytoma (P=.204) relative to the control. Ghrelin level was significantly higher in carcinoma compared to adenoma (P=.049) samples. A positive correlation between ghrelin and IGF2 expression was observed only in myelolipoma (P=.001). Ghrelin at concentrations of 1x10(-6)mol/L and 1x10(-8)mol/L significantly stimulated proliferation and migration rate in the H295R cell line. ConclusionGhrelin appears to be an essential factor in driving adrenal tumours development.

引用

页码：36 / 45

页数：10

共 35 条

[11] Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness [J].

Duxbury, MS ;

Waseem, T ;

Ito, H ;

Robinson, MK ;

Zinner, MJ ;

Ashley, SW ;

Whang, EE .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) :464-468

[12]

Farrugia F A, 2017, Endocr Regul, V51, P168, DOI 10.1515/enr-2017-0018

[13]

Fassnacht M, 2009, CANCER, V115, P243, DOI DOI 10.1002/CNCR.24030

[14] Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer [J].

Gronberg, Malin ;

Ahlin, Cecilia ;

Naeser, Ylva ;

Janson, Eva Tiensuu ;

Holmberg, Lars ;

Fjallskog, Marie-Louise .

PLOS ONE, 2017, 12 (04)

[15] Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer [J].

Gronberg, Malin ;

Fjallskog, Marie-Louise ;

Jirstrom, Karin ;

Janson, Eva T. .

ACTA ONCOLOGICA, 2012, 51 (03) :386-393

[16] IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma [J].

Guillaud-Bataille, Marine ;

Ragazzon, Bruno ;

de Reynies, Aurelien ;

Chevalier, Claire ;

Francillard, Isabelle ;

Barreau, Olivia ;

Steunou, Virginie ;

Guillemot, Johann ;

Tissier, Frederique ;

Rizk-Rabin, Marthe ;

Rene-Corail, Fernande ;

Al Ghuzlan, Abir ;

Assie, Guillaume ;

Bertagna, Xavier ;

Baudin, Eric ;

Le Bouc, Yves ;

Bertherat, Jerome ;

Clauser, Eric .

PLOS ONE, 2014, 9 (08)

[17] Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines [J].

Jeffery, PL ;

Murray, RE ;

Yeh, AH ;

McNamara, JF ;

Duncan, RP ;

Francis, GF ;

Herington, AC ;

Chopin, LK .

[18] Deficits in the Management of Patients With Adrenocortical Carcinoma in Germany [J].

Johanssen, Sarah ;

Hahner, Stefanie ;

Saeger, Wolfgang ;

Quinkler, Marcus ;

Beuschlein, Felix ;

Dralle, Henning ;

Haaf, Michaela ;

Kroiss, Matthias ;

Jurowich, Christian ;

Langer, Peter ;

Oelkers, Wolfgang ;

Spahn, Martin ;

Willenberg, Holger S. ;

Maeder, Uwe ;

Allolio, Bruno ;

Fassnacht, Martin .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (50) :885-U9

[19] Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].

Kojima, M ;

Hosoda, H ;

Date, Y ;

Nakazato, M ;

Matsuo, H ;

Kangawa, K .

NATURE, 1999, 402 (6762) :656-660

[20]

Komarowska H, 2012, NEUROENDOCRINOL LETT, V33, P749

← 1 2 3 4 →